Safety and Immunogenicity of Two Doses of a Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Indian and Russian Children Aged 9 to 17 Months.

Journal: Indian pediatrics
PMID:

Abstract

OBJECTIVE: Evaluation of tolerability, safety and immunogenicity of a two-dose series of a quadrivalent meningococcal polysaccharide diptheria toxoid conjugate (ACYW-D) vaccine in Indian and Russian infants/toddlers.

Authors

  • Bakul Javadekar
    Department of Pediatrics, Medical College and SSG Hospital, Baroda, SSG Hospital Campus, Raopura, Vadodara, Gujarat, India.
  • Apurba Ghosh
    Institute of Child Health, Kolkata, West Bengal, India.
  • Rajeev Zachariah Kompithra
    Well Baby Clinic, Department of Child Health, Christian Medical College, Vellore, Tamilnadu, India.
  • Shally Awasthi
    Department of Pediatrics, Shahuji Maharaj Medical University, Lucknow, Uttar Pradesh, India.
  • Olga Perminova
    City Children's Policlinic No 5, Perm, Russia.
  • Viktor Romanenko
    Municipal City Children Hospital #11, Ekaterinburg, Russia.
  • Vera Rodnikova
    Murmansk Children's City Hospital, Murmansk, Russia.
  • Susanna Kharit
    Research Institute for Pediatric Infectious Diseases, St. Petersburg, Russia.
  • Yael Thollot
    Sanofi Pasteur, Lyon, France.
  • Valerie Bosch-Castells
    Sanofi Pasteur, Marcy l'Etoile, France.
  • Alexander Goldstein
    Sanofi Pasteur, Moscow, Russia.
  • Himanshu Dubey
    Medical Affairs, Sanofi Pasteur, Mumbai, India. Correspondence to: Dr Himanshu Dubey, Sanofi House, CTS No. 117-B, L and T Business Park, Saki Vihar Road, Powai, Mumbai 400 072, India. Himanshu.Dubey@sanofi.com.